⮝ Full datasets listing
PXD076537
PXD076537 is an original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Quantification of proinsulin in human plasma by proteolysis-aided peptide immunoaffinity-LC-MS/MS |
| Description | Background: Plasma proinsulin concentrations are used diagnostically to investigate hypoglycemia. They have also been proposed as a marker of β-cell function, particularly as a ratio with C-peptide. Immunoassays remain the primary method for measuring proinsulin despite potential limitations. Mass spectrometry-based assays have been described, but are semiquantitative or rely on nano-flow liquid chromatography, which is not suitable for routine clinical use. We aimed to develop a normal-flow liquid chromatography-tandem mass spectrometry assay (LC-MS/MS) to quantify proinsulin and its partially processed forms in human plasma and ensure accuracy over time with distributable well-characterized calibrators. Methods: Sample preparation consists of protein precipitation, Glu-C digestion, peptide immunoaffinity enrichment, and LC-MS/MS analysis of two surrogate peptides. The peptide RGFFYTPKTRREAE spans the cleavage site for des-31,32-proinsulin and GSLQKRGIVE spans the site for des-64,65-proinsulin. A purified protein calibration material was characterized and used to value-assign a matrix-matched single-point calibration material. Results: The assay demonstrated good precision and linearity, with a lower limit of the measuring interval of 2.8 pM for RGFFYTPKTRREAE and 8.8 pM for GSLQKRGIVE. The concentration des-31,32-proinsulin increased more during childhood than intact proinsulin. Participants with type 1 diabetes-associated autoantibodies had higher proinsulin-to-C-peptide ratios. Method comparison with two commercial immunoassays revealed variable cross-reactivity with insulin. Conclusion: The validated assay is robust and will be a useful tool for advancing studies of β-cell function. A detailed standard operating procedure, well-characterized calibration material, and monoclonal antibodies are available to facilitate adoption in other laboratories. |
| HostingRepository | PanoramaPublic |
| AnnounceDate | 2026-07-27 |
| AnnouncementXML | Submission_2026-07-27_17:16:48.583.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Non peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Supported dataset by repository |
| PrimarySubmitter | Sara Shijo |
| SpeciesList | scientific name: Homo sapiens; NCBI TaxID: 9606; |
| ModificationList | Label:13C(6)15N(4) |
| Instrument | Triple Quad 6500+ |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
|---|---|---|---|
| 0 | 2026-04-02 21:28:50 | ID requested | |
| ⏵ 1 | 2026-07-27 17:16:49 | announced |
Publication List
| no publication |
Keyword List
| submitter keyword: proinsulin, partially processed proteoforms, diabetes, endoproteinase Glu-C, single-point calibration, antibody enrichment |
Contact List
| Andy Hoofnagle | |
|---|---|
| contact affiliation | University of Washington |
| contact email | ahoof@uw.edu |
| lab head | |
| Sara Shijo | |
| contact affiliation | University of Washington |
| contact email | sshijo@uw.edu |
| dataset submitter | |
Full Dataset Link List
| Panorama Public dataset URI |




